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Summary 
 
Monopolar spindle 1 (Mps1) is a conserved apical kinase in the spindle assembly 
checkpoint (SAC) that ensures accurate segregation of chromosomes during mitosis. 
Mps1 undergoes extensive auto- and trans-phosphorylation, but the regulatory and 
functional consequences of these modifications remain unclear. Recent findings highlight 
the importance of intermolecular interactions between the N-Terminal extension (NTE) 
of Mps1 and the Hec1 subunit of the NDC80 complex, which control Mps1 localization 
at kinetochores and activation of the SAC. Whether the NTE regulates other mitotic 
functions of Mps1 remains unknown.  Here, we report that phosphorylation within the 
NTE contributes to Mps1 activation through relief of catalytic autoinhibition that is 
mediated by the NTE itself. Moreover, we find that this regulatory NTE function is 
independent of its role in Mps1 kinetochore recruitment. We demonstrate that the NTE 
autoinhibitory mechanism impinges most strongly on Mps1-dependent SAC functions, 
and propose that Mps1 activation likely occurs sequentially through dimerization of a 
‘prone-to-autophosphorylate’ Mps1 conformer, followed by autophosphorylation of the 
NTE prior to maximal kinase activation segment trans-autophosphorylation. Our 
observations underline the importance of autoregulated Mps1 activity in generation and 
maintenance of a robust SAC in human cells. 
 
Keywords: Mitosis, kinetochore, Mps1, SAC, autoinhibition, autoactivation, kinase, 
checkpoint  
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Introduction 
Cell division is orchestrated by a precise and highly regulated series of events. To avoid 
errors in chromosome segregation during mitosis and meiosis, the cell has evolved a 
signaling mechanism called the Spindle Assembly Checkpoint (SAC) [1-3]. The SAC 
monitors the robustness of spindle microtubule attachments during mitosis and delays the 
onset of anaphase until all sister chromatids become appropriately attached. SAC activity 
initiates at kinetochores, complex protein structures that form at centromeres and mediate 
the interaction between dividing sister-chromatids and spindle microtubules during 
mitosis [2, 3]. Microtubule capture is thought to occur at the outer kinetochore by the 
KMN network (KNL1 Complex, NDC80 complex and MIS12 complex) [4] and some 
components of this network, in particular Hec1 and Knl1, are directly involved in SAC 
establishment. Knl1 is a major signaling hub during mitosis, and its phosphorylation by 
Mps1, or alternatively by Plk1, under conditions where Mps1 activity is compromised or 
does not exist as in certain nematodes, initiates SAC signaling. In contrast, 
dephosphorylation by a PP2A-PP1 relay is thought to be a major mechanism of 
attenuating the SAC [5-7].   
Mps1 has emerged as a master conductor of SAC signaling, and is one of the first protein 
kinases recruited to unattached kinetochores in early mitosis [8]. Mps1 activity is 
regulated by a cooperative series of auto and transphosphorylation reactions that appear 
to be dependent on Mps1 and Plk1 [6, 9-11]. Activated Mps1 phosphorylates the KNL 
complex at conserved Thr residues in so-called MELT (for Met-Glu-Leu-Thr core 
consensus) repeat motifs. This generates high affinity binding sites for Bub3 and 
promotes recruitment of a Bub1-Bub3-BubR1-Bub3 heterotetrameric complex to 
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kinetochores [12-19]. Recent reports suggest that phosphorylation of Bub1 by Mps1 
promotes its binding to the Mad1-Mad2 heterodimer [20-22]. Mad1-Mad2 complex 
formation and activation occurs through a templating mechanism and involves the 
conversion of an “open” O-Mad2 to a SAC-competent, “closed” C-Mad2 conformation 
[23]. Mps1 activity is required for retaining both the Mad1-C-Mad2 complex and O-
Mad2 at unattached kinetochores during mitosis [24]. In line with these pleotropic 
functions, depletion of Mps1 [25, 26] or chemical inhibition of its catalytic activity [9, 
27, 28] confirmed a requirement for Mps1 in proper chromosome alignment and accurate 
chromosome segregation.  
Critical to human Mps1 activity is its localization to the kinetochore, which in human 
cells is primarily mediated by the non-catalytic NTE (N-Terminal Extension), with a 
minor contribution from the MR (middle region). Together these regions sandwich a TPR 
(Tetratricopeptide Repeat) motif which also plays a role in Mps1 localization [29-34]. 
The NTE is a region of about fifty amino acids at the extreme N-terminus; it is rather 
poorly conserved and lacks clear structural and functional domains. Recent evidence 
suggests that human Mps1 localization is primarily controlled by the NTE through 
competition with microtubules for their binding site on the calponin homology (CH) 
domain of Hec1 [35] although budding yeast Mps1 can also directly associate with 
attached kinetochores [36]. The Mps1 MR contributes to Mps1 localization through 
interactions with the CH domain of Nuf2 that appear to be regulated by Aurora B 
phosphorylation [32, 35, 37]. Despite poor conservation, the N-terminus of fission yeast 
Mph1 is also required for its kinetochore recruitment to the NDC80 complex, albeit by 
potentially different mechanisms [38, 39]. Curiously, in budding yeast the NTE has been 
5 
 
reported to contribute to Mps1 kinase activity [40]. Our previous studies of human Mps1 
also confirm that the N-terminus of Mps1 promotes catalytic activation [30], although 
whether this functionality is associated with the NTE or the TPR remains unclear [29-31]. 
Taken together, these observations raise the intriguing possibility that the NTE of human 
Mps1 may be involved in the regulation of Mps1 kinase activity, in addition to a well-
established role in kinetochore docking.  
In this study, we found that the NTE contributes to Mps1 catalytic activation that is 
independent of its role in kinetochore docking. We show that residues 40-49 in the NTE 
are required for full kinase activation independent of Hec1 binding.  In particular, 
phosphorylation of this region promotes relief of NTE-specific autoinhibition, which is 
required for optimal SAC activity. An Mps1 mutant protein lacking residues 40-49 and 
mutated at adjacent phosphorylation sites fully restores kinase and SAC function, 
suggesting that multiple phosphorylation events in the Mps1 NTE are required for 
complete activation of Mps1. Together, our data confirm that the Mps1 NTE contributes 
to robust activation of the SAC through relief of autoinhibition, in addition to its 
established role in kinetochore binding. 
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Results 
Mps1-ΔNTE exhibits both attenuated activity and kinetochore localization 
To evaluate the potential role of the NTE in Mps1 localization and catalytic activity, we 
generated an Mps1 construct lacking the first 49 amino acids (Mps1-ΔNTE, Figure 1A). 
In agreement with previous studies [31], MYC-Mps1-ΔNTE localized weakly at 
kinetochores after depletion of endogenous Mps1 (Figure S1), even after inhibition of 
Mps1 activity with reversine, which decreases Mps1 turnover at kinetochores [41] 
(Figure 1B). This extends previous reports and establishes that the effect of Mps1 activity 
on localization is negligible in the absence of the NTE. As a measure of Mps1 activation 
we used phosphospecific antibodies recognizing Mps1 activation loop pT676 and pT686 
[6, 11]. In cells depleted of endogenous Mps1, MYC-Mps1 wild-type (WT) exhibited 
robust phosphorylation at the activation loop (T676) and P+1 loop (T686) sites (together 
referred to as the activation segment) whereas both MYC-Mps1 kinase-dead (D664A, 
KD) and MYC-Mps1-ΔNTE exhibited much lower levels of phosphorylation (Figure 
1C). Phosphorylation of a proline-directed site (S821) was only marginally decreased in 
MYC-Mps1-ΔNTE.  Mps1-ΔNTE also exhibited attenuated gel retardation when 
compared with Mps1-WT, characteristic of reduced activity-dependent 
autophosphorylation (Figure S2). Finally we measured in vitro catalytic output using both 
Mps1 autophosphorylation and phosphorylation of MBP (Myelin Basic Protein) (Figure 
1D, E). As expected, Mps1-WT was efficient at both auto- and substrate phosphorylation, 
whereas Mps1-KD was completely ineffective at both. Surprisingly, and in contrast to 
observations with the phosphospecific antibodies in cell extracts, the isolated Mps1-
ΔNTE phosphorylated both itself and MBP as efficiently as Mps1-WT. 
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Mps1 clustering by the NTE supports Mps1 kinase activity 
One possible interpretation of the discordance between the results obtained with 
phosphospecific antibodies and in vitro kinase assays is that a high degree of antibody-
mediated Mps1 clustering induced by immunoprecipitation prior to the in vitro kinase 
assay may serve to promote Mps1 autoactivation in trans [26, 42] [9, 10, 42, 43]. A 
cellular function of Mps1 kinetochore localization might therefore be increasing the local 
concentration of Mps1 to trigger autoactivation [42]. To test this idea, we expressed Lac 
repressor (LACI) fusion proteins with Mps1 in U2OS cell lines expressing 256 copies of 
the Lac operator in chromosome 1 [44]. In nocodazole-arrested cells, MYC-LACI-Mps1-
WT (but not Mps1-KD) was phosphorylated at T686, as expected. In contrast, MYC-
ΔNTE was very poorly phosphorylated at this site, whereas MYC-LACI-Mps1-ΔNTE 
was able to autophosphorylate efficiently (Figure 2A). These results were confirmed 
using quantitative immunofluorescence (Figure 2B, C). In agreement, forced kinetochore 
localization of Mps1-ΔNTE via N-terminal fusion to the kinetochore component Mis12 
(Figure S3A) restored Mps1-ΔNTE autophosphorylation at both T686 and T676 to levels 
comparable to Mps1-WT (Figure 2D). To test the idea that dimerization of Mps1-ΔNTE 
may promote its activity regardless of subcellular localization, we exploited chemical-
induced dimerization.  To accomplish this, we generated Mps1 proteins fused to the 
FK506-binding protein (FKBP) which homodimerizes in the presence of the small 
molecule ligand, AP20187. In nocodazole-arrested cells treated with AP20187, MYC-
Mps1-ΔNTE was poorly phosphorylated, whereas AP20187 treatment resulted in a 
rescue of autophosphorylation at T686 in MYC-FKBP-Mps1-ΔNTE expressing cells to 
levels similar to those observed with Mps1-WT.  As expected, MYC-FKBP-Mps1-KD 
8 
 
was not autophosphorylated at T686 (Figure 2E). Thus, enforced Mps1-ΔNTE 
dimerization in the cytoplasm during mitosis is sufficient to induce its activation, 
confirming the importance of Mps1 clustering for activation through promotion of 
autophosphorylation.   
To provide functional evidence for this mechanism, we verified the effect of clustering 
endogenous Mps1 at kinetochores, by measuring phosphorylation of the physiological 
Mps1 substrate Knl1 with pT875 phosphospecific antibodies (hereafter referred to as 
pMELT [13, 14, 16-19]. Treatment with taxol and nocodazole has been proposed to 
differentially affect Mps1 recruitment levels; taxol-hyperstabilized microtubules are 
thought to compete with (and therefore decrease) Mps1 localization at kinetochores, 
whereas nocodazole destabilizes microtubule interactions, associated with increased 
recruitment of Mps1 to kinetochores [35]. We confirmed these observations (Figure 
S3E), and demonstrated that in both HeLa S3 (Figure 2F and Figure S3D) and RPE-1 
(Figure S3B, C) cells, pMELT:Mps1 signals at kinetochores was significantly lower in 
taxol-arrested cells when compared to nocodazole arrested cells. Collectively these data 
imply that there is a negative correlation between Mps1 kinetochore occupancy and 
substrate phosphorylation, and that NTE-mediated kinetochore localization contributes to 
Mps1 activation.  
Dissection of the NTE reveals an autoinhibitory motif regulating kinase activity  
Our data thus far suggest that the Mps1 NTE promotes high local concentrations of the 
kinase at kinetochores, which contributes to its own optimal activation. We next sought 
to determine the specific region of the NTE that drives this process. Although the NTE is 
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rather poorly conserved, N-terminal alignment of multicellular eukaryote sequences 
revealed three short regions of conservation within the first 49 amino acids that we 
reasoned might be important for NTE functions (Figure 3A). We therefore generated a 
panel of different Mps1 mutants: the deletion mutants Mps1-Δ7, Mps1-Δ19-29, and 
Mps1-Δ40-49, as well as Mps1-5A, which consists of alanine mutations of a conserved 
acidic region (30-31-33-34-35) including the previously identified autophosphorylation 
site T33 [45].   
Using phosphospecific Mps1 antibodies, we tested phosphorylation of these mutants 
together with Mps1-'TPR. As expected, Mps1-WT, but not Mps1-KD, was 
phosphorylated at both T686 and T676, whereas Mps1-ΔNTE displayed markedly 
decreased autophosphorylation as described above. Mps1-Δ7, Mps1-Δ19-29 and Mps1-
5A displayed only very slightly reduced levels of Mps1 autophosphorylation compared to 
Mps1-WT. In contrast, Mps1-Δ40-49 and Mps1-'TPR exhibited decreased 
phosphorylation profiles that were similar to Mps1-ΔNTE (Figure 3B). Individual HeLa 
cells depleted of endogenous Mps1 and expressing Mps1-Δ40-49 also displayed a 
significantly attenuated pT686 signal compared to cells rescued with Mps1-WT (Figure 
3C). This suggests that while multiple regions of the NTE may incrementally contribute 
to Mps1 activity, residues 40-49 in the NTE play a more significant role in Mps1 
catalytic autoactivation.  
Our data reveal that Mps1 clustering at the kinetochore via the NTE promotes its 
activation, and so we next sought to determine the subcellular localization of Mps1-Δ40-
49, reasoning that these residues might contribute to Hec1 binding, which is required for 
optimal kinetochore association. We examined the localization of the Mps1 mutants 
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while concomitantly depleting endogenous Mps1 to prevent dimerization with the 
endogenous protein. Surprisingly, Mps1-Δ40-49 behaved like Mps1-WT, whereas Mps1-
ΔNTE localized very weakly to kinetochores in the absence or presence of reversine 
(Figure 3D, E) as previously established (Figure 1B). In agreement with these 
observations, Mps1-ΔNTE associated more weakly with recombinant GST-CHHEC1 in 
pulldown experiments, whereas Mps1-WT and Mps1-Δ40-49 were bound to GST-
CHHEC1 at similar levels (Figure 3F).  Collectively, our data suggest that while Mps1 
kinetochore docking helps to promote catalytic activity, the enzymatic and localization 
functions of the Mps1-NTE can be uncoupled.   
  
Residues 40-49 form an NTE-specific kinase autoinhibitory module  
Considering that immunoprecipitation and clustering of Mps1-ΔNTE restored catalytic 
activity, we reasoned that NTE residues 40-49 might be involved in Mps1 dimerization 
and catalytic activation. Similar reasoning also led us to hypothesize that clustering by 
immunoprecipitation of the Mps1-'TPR deletion mutant, which localizes less efficiently 
than Mps1-WT to kinetochores [31], might restore activity. Consistently Mps1-ΔNTE 
and Mps1-'TPR demonstrated levels of activity equivalent to Mps1-WT when 
immunoprecipitated and subjected to in vitro kinase assays (Figure 4A). Interestingly, 
immunoprecipitated, clustered Mps1-Δ40-49 still exhibited reduced activity, whereas that 
of a distinct deletion mutant (Mps1-Δ19-29) was comparable to Mps1-WT, suggesting 
that amino acids 40-49 are required for Mps1 activation. The observation that clustering 
restores full kinase activity to Mps1-ΔNTE and Mps1-ΔTPR, but not Mps1-Δ40-49 
strongly suggests that residues 40-49 are required to modulate Mps1 autoinhibition by the 
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NTE itself. To test this idea directly, we generated double mutants of the NTE, 
combining the 40-49 deletion with other NTE mutants, namely Δ19-29, Δ7 and 5A, and 
assessed autophosphorylation in cell extracts. The Mps1 Δ40-49/5A double mutant 
exhibited autophosphorylation to levels comparable with that of Mps1-WT (Figure 4B). 
The activity of two other double mutants, Mps1-Δ40-49/Δ7 and Mps1-Δ40-49/Δ19-29, 
remained unchanged compared to Mps1-Δ40-49.  
The 40-49 region harbors several potential phosphorylation sites including 
residues T45, T46, and the bona fide autophosphorylation site S49 (Figure 3A)[46], 
raising the possibility that autoinhibition may be a result of the loss of phosphorylation in 
this region. Collective mutation of all three sites to alanine (Mps1-3A) resulted in a 
marked decrease of Mps1 phosphorylation at T686, which was rescued by a triple 
phosphomimetic Mps1-3E mutant (Figure 4C, top 3 panels).  These data suggest that 
phosphorylation of a short autoinhibitory motif in the NTE is required for full activation 
of Mps1, likely through release of an NTE-specific autoinhibitory segment. 
The unexpected finding that phosphorylation in the Mps1 NTE is required for 
efficient Mps1 autophosphorylation and catalytic activation suggested that NTE 
phosphorylation might occur prior to maximal activation segment phosphorylation. To 
evaluate this idea more closely, we sought to determine the phosphorylation of the NTE 
in the hypoactive Mps1-Δ40-49 mutant. We generated a phosphospecific antibody 
against T33 (Figure S4), an Mps1 autophosphorylation site [45, 47, 48], and one of the 
residues implicated in driving relief of autoinhibition by the NTE. We found that Mps1-
3A and Mps1-3E exhibited T33 phosphorylation that was equivalent to Mps1-WT, 
whereas neither Mps1-ΔNTE nor Mps1-KD was phosphorylated (Figure 4C, bottom 
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panel), confirming that T33 is indeed an Mps1 autophosphorylation site. Consistently, 
Mps1-Δ40-49 and Mps1-WT exhibited comparable phosphorylation at T33 despite a 
decrease in T686 and T676 phosphorylation compared to Mps1-WT (Figure 4D). 
Phosphorylation of all mutants at S821 was comparable between Mps1 proteins (Figure 
4C, D). These observations demonstrate that NTE T33 phosphorylation, in contrast to 
activation segment phosphorylation, is insensitive to the NTE autoinhibitory ‘module’.  
We next sought to better understand the initial steps involved in Mps1 activation. Co-
transfection of differentially tagged Mps1 WT and KD resulted in phosphorylation of the 
KD mutant at both T686 and T33, indicating that NTE phosphorylation occurs in trans 
(Figure S5A). In addition, we tested NTE phosphorylation by Plk1 which share a similar 
substrate consensus as Mps1 and has been implicated in Mps1 activation [6, 7]. We 
established that the NTE is a poor substrate for Plk1, at least in vitro, whereas it was 
efficiently phosphorylated by Mps1 (Figure S5B-E); residual phosphorylation is likely 
due to other target Mps1 sites in the NTE, TPR or both. Finally, Plk1 inhibition resulted 
in a consistent decrease of Mps1 T686 phosphorylation in both Mps1-WT and Mps1-
Δ40-49 expressing cells, indicating that Plk1 contributes to Mps1 activation 
independently of the NTE (Figure S5F).  
The Mps1 NTE interacts directly with the kinase domain 
Intermolecular NTE phosphorylation by Mps1 requires a topology in which sites 
proximal to the NTE interact with the active Mps1 in order to promote phosphorylation. 
We evaluated such a mechanism in vitro by employing stable, 6xHis-tagged recombinant 
Mps1 fragments that were isolated after limited proteolysis (Figure 5A).  Mps1 N-
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terminal fragments (residues 1-301, 1-225, and 27-225) were incubated with recombinant 
6xHis-tagged C-terminal Mps1 fragments (residues 302-859 and 510-809) and then 
immunoprecipitated with an Mps1 C-terminus antibody. All N-terminal Mps1 fragments 
interacted directly with both C-terminal fragments of Mps1 (Figure 5B). Next, we used 
velocity sedimentation to determine complex formation between N and C-terminal Mps1 
fragments (Figure 5C). After co-incubation with Mps1-N(1-225), Mps1-C(510-809) 
displayed a shifted sedimentation profile indicating efficient complex formation. Finally, 
we tested association between Mps1-N(1-225) an Mps1-C(510-809) fragments by 
analytical size exclusion chromatography, which confirmed direct complex formation 
between the N- and C-termini of Mps1 (Figure 5D). 
To fine-map intramolecular Mps1 interactions, and further explore the dependence of 
these interactions on Mps1 activity, we employed chemical cross-linking and mass 
spectrometry. GST-Mps1-WT and KD purified to homogeneity from insect cells were 
individually crosslinked with bis(sulfosuccinimidyl)suberate (BS3), prior to peptide 
identification by mass-spectrometry (Figure 5E, F, See also Tables S1 and S2). 
Importantly, we established that the chemical cross-linking map of Mps1-WT and Mps1-
KD varied greatly with only a small number of shared crosslinks, and with Mps1-WT 
forming a far greater number of unique cross-links than Mps1-KD (Figure 5E). This 
suggests the existence of significant conformational differences between catalytically 
active (and highly phosphorylated) and inactive full-length Mps1 polypeptides [49].  
Interestingly, interactions formed between the NTE and kinase domain of Mps1 were 
only identified in Mps1-WT and not Mps1-KD crosslinks, suggesting that Mps1 
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autophosphorylation and activation is coincident with direct interactions between its N- 
and C- termini.  
Mps1 NTE-mediated relief of autoinhibition is required for SAC activity but not 
chromosome segregation fidelity  
To explore the cellular consequences of NTE-mediated Mps1 autoinhibition on critical 
mitotic functions of Mps1, we generated a panel of HeLa T-Rex stable cell lines 
expressing Mps1 NTE mutants (Figure S6 A-D), and tested the effect of various NTE 
deletions and mutations on SAC dynamics, mitotic timing, and chromosome congression 
in cells simultaneously depleted of endogenous Mps1. As a first test for SAC signaling, 
we examined MELT motif phosphorylation. Mps1-WT expressing cells demonstrated 
robust pMELT signals, whereas Mps1-Δ40-49 and ΔNTE expressing cells exhibited a 
significant decrease in MELT motif phosphorylation, indicative of attenuated SAC 
signals (Figure 6A). MELT phosphorylation initiates the signaling cascade that ultimately 
results in the accumulation of MAD2 at kinetochores. We therefore determined the levels 
of O-MAD2 recruited to kinetochores, confirming that expression of Mps1-Δ40-49 
significantly reduced O-MAD2 recruitment (Figure 6B)[50]. Finally, we measured 
mitotic arrest in the presence of nocodazole, and found that Mps1-Δ40-49 expressing 
cells exhibited a significantly lower mitotic index when compared to Mps1-WT (Figure 
6C). Importantly, in a cell line expressing Mps1-'40-49/5A in which Mps1 activation 
loop phosphorylation was recovered (Figure 4B), the SAC-arrest defect was also rescued 
(Figure 6D, Figure S6C,D). We next used live cell imaging to determine the duration of 
mitosis (defined by the time interval between nuclear envelope breakdown and anaphase 
onset) in our stable cells lines. Mitotic timing was markedly decreased from an average 
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of 40.8 ± 2.09 mins for siGL2 treated cells to 26.32 ± 0.94 mins (p<0.0001 one-way 
analysis of variance (ANOVA)) in Mps1-depleted cells in agreement with previous 
literature (Figure S6E) [25, 26, 37, 51]. MYC-GFP Mps1 WT rescued mitotic timing 
(43.78 ± 3.25 mins), whereas Mps1 KD and Mps1-ΔNTE did not, with an average 
duration of 22.51 ± 0.97 mins and 30.40 ± 1.25 mins respectively (p<0.0001, ANOVA) 
(Figure 6E). Although Mps1-Δ40-49 expressing cells completed mitosis at a significantly 
faster rate than Mps1-WT expressing cells, this effect was not as pronounced as that 
observed with the other NTE mutants (34.21 ± 1.46 mins (p<0.001, ANOVA), see 
Movies S1-S4).  Thus the 40-49 NTE motif is required for full SAC function in addition 
to efficient mitotic timing.  
 Alongside SAC signalling, Mps1 kinase activity also regulates kinetochore-microtubule 
interactions [9, 25-28, 46]. To examine the role of the NTE-mediated partial 
autoinhibition in this process, we evaluated the extent of lagging chromosomes in 
anaphase (Figure 7A). This phenotype was most pronounced in cells expressing Mps1-
KD, with approximately 60% of the cells displaying lagging chromosomes. Cells 
expressing Mps1-ΔNTE displayed lagging chromosomes in approximately 43% of cells 
respectively (p<0.001, 2-way ANOVA), whereas Mps1-Δ40-49 expressing cells showed 
no apparent increase in lagging chromosomes when compared to Mps1-WT (p>0.9999, 
2-way ANOVA), even in the presence of low doses of nocodazole to induce spindle 
stress (Figure 7B). To understand why Mps1 '40-49 only attenuated the SAC functions 
of Mps1, we examined the effect of Mps1 partial inhibition on specific Mps1 substrates 
involved in supporting the SAC (pMELT) and chromosome congression (SKA3 pS34, 
[46]). In response to increasing doses of reversine MELT motif phosphorylation was 
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significantly more sensitive to Mps1 inhibition than SKA pS34 (Figure 7C). This is in 
agreement with very recent observations demonstrating a preference for pThr over pSer 
residues by PP2A upon mitotic exit [52], and potentially explains why the partial 
inhibition of Mps1-'40-49 impinges more strongly on the SAC, rather than chromosome 
segregation.   
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Discussion 
Mps1 lies at, or near, the apex of the SAC signaling cascade and its localisation at 
kinetochores serves an important role in increasing the local concentrations of Mps1 at its 
site of action, which in turn promotes Mps1 catalytic activity (Figure 2). We confirm that 
the Mps1 N-terminal region contributes to the SAC by mediating kinetochore docking of 
Mps1 (Figure 1A-B) [29, 31, 32, 35]. Moreover, the NTE also contributes to the SAC via 
an additional localization-independent mechanism: autoinhibition of Mps1 kinase 
activity. Autoinhibition is a common safety feature built into kinase regulation that 
prevents premature auto-phosphorylation until triggered by an external stimulus [53]. In 
the case of Mps1, we suggest that autoinhibition might be necessary to ensure no basal 
SAC signaling in the absence of improper microtubule attachments of sister chromatids.  
In this study, we demonstrate that the NTE participates in Mps1 autoinhibition, 
leading to attenuation of activation loop phosphorylation. We futher establish that 
autophosphorylation in the NTE is important to release this autoinhibition, which 
subsequently permits activation of Mps1 through maximal phosphorylation in the 
activation segment. In its partially autoinhibited form, residual Mps1 activity does not 
support a full SAC response, but appears to be sufficient to promote productive 
microtubule attachments, possibly as a result of the differential sensitivity of substrates to 
local dephosphorylation (Figure 7C). Our data are thus consistent with a model where 
Mps1 activation is a complex, multistep process that requires initial dimerization leading 
to allosteric stabilization of a partially active, ‘prone-to-autophosphorylate’ transient 
Mps1 conformer prior to trans-autophosphorylation at multiple sites in the Mps1 NTE 
residing between residues 30 and 50 [54]. This mechanistic switch then releases a partial 
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NTE-specific autoinhibition, enabling activation segment phosphorylation at T676 and 
T686 (Figure 7D) which are known to be associated with kinase activation [10, 11, 55, 
56]. An attractive model is that NTE phosphorylation and association with the kinase 
domain may result in a disorder-to-order conformational transition in this region, 
allowing the release of autoinhibition and promotion of catalytic autoactivation. 
Importantly, the effect of autoinhibition only occurs in the context of the full-length 
Mps1 molecule.  In the absence of the NTE or the TPR, the decrease in kinase activity is 
a result of the loss of efficient Mps1 kinetochore docking and clustering (Figure 2, 3B) 
[29-31]. Considering that T33 is one of the residues whose mutation rescues kinase 
activity in the Mps1-Δ40-49 mutant, its mechanism of phosphorylation is insensitive to 
the partial autoinhibition imposed by the NTE (Figure 4).  To the best of our knowledge, 
this is the first example of a graded response to catalytic autoinhibition between 
individual autophosphorylation sites in Mps1, or any other mitotic kinase.  
How might NTE phosphorylation relieve catalytic autoinhibition? Our in vitro binding 
and cross-linking experiments revealed unique interactions between the NTE of Mps1 
and its kinase domain that are absent in Mps1-KD, which lacks autophosphorylation [49]. 
This is in agreement with the idea that NTE phosphorylation is Mps1-dependent, and 
strongly supports our model that NTE phosphorylation is required for efficient Mps1 
activation at levels that fully support mitotic functions.  Mapping the kinase domain 
residues identified in the cross-links with the NTE onto the Mps1 kinase structure 
suggests that the NTE region interacts with the N-terminal lobe at the residues 
V539FQVLNEKK547 and Q579QHSDKIIR587. Our crystal structure of the Mps1 catalytic 
domain in an inhibited conformation [55] shows that residues in the Q579QHSDKIIR587 
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region form part of the DC-helix, a structural feature critical to kinase activity, and are in 
close spatial proximity (5 Å or less) to the activation segment and catalytic loops (Figure 
S7). We thus anticipate that the Mps1 NTE and kinase domain interact to trigger long 
range conformational changes that fine-tune phosphorylation of Mps1 substrates and the 
maintenance of high kinase activity. Structural studies of the full-length active and 
inactive Mps1 will be required to further test our models, and reveal the precise 
mechanism through which NTE phosphorylation promotes activation loop 
phosphorylation in Mps1. However, our study provides a mechanistic framework for 
understanding how Mps1 catalytic activity is autoinhibited, primed and then generated, 
and advances our understanding of the fine-tuning mechanisms by which Mps1 exerts 
control over the SAC in human cells. 
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Figure legends: 
Figure 1. Mps1-ΔNTE exhibits attenuated activity and kinetochore localization: (A) 
Mps1 domains and phosphorylation sites relevant to this study. (B) Mitotic cells 
expressing Myc-GFP-Mps1 WT and ΔNTE and siMps1 were treated and immunostained 
as indicated. Scale bar = 5µm. Quantification shows the MYC-Mps1/Hec1 ratio. **** 
p < 0.0001. (C) Phosphorylation of MYC-Mps1 -WT, -KD, or -ΔNTE expressed in 
Mitotic HEK-293T cells together with Mps1 siRNA. (D) In vitro kinase assay of MYC-
GFP-Mps1 -WT, -KD and -ΔNTE expressed as in (C), and visualized by autoradiography 
(first and third panels). Coomassie Blue shows equal loading. (E) Quantification of Mps1 
autophosphorylation from (D). Data are means ± S.E.M from n = 2 independent 
experiments. *** p < 0.001. See also Figures S1 and S2. 
Figure 2. Mps1 clustering in the NTE supports its kinase activity: (A) Immuno 
blotting with the indicated antibodies of MYC-LacI-Mps1 -WT, -KD, -ΔNTE, or MYC-
Mps1-ΔNTE expressed with siMps1 in a U2OS line expressing a LACO array and 
enriched in mitosis. (B) Cells were treated as in (A) but fixed for immunofluorescence as 
indicated. Scale bar = 5µm. (C) Quantification of pT686/MYC-Mps1 ratios from (B). * 
p < 0.05, n=3. (D) Immunoblotting was performed with the antibodies shown on lysates 
from cells expressing the indicated Mps1 constructs. (E) Cells were transfected with the 
indicated MYC-FKBP-Mps1 constructs together with siMps1, synchronized in mitosis, 
and treated with 10nM AP20187 1h before immunoblotting as indicated. Note that an 
intermittent band has been excised out. (F) HeLa cells were treated overnight with the 
indicated drugs before fixation. Quantification of pMELT/Mps1 ratios is shown. ** p < 
0.01. See also Figure S3. 
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Figure 3. Dissection of the NTE reveals an autoinhibitory motif regulating kinase 
activity: (A) Evolutionary conservation of the Mps1 NTE and deletion mutants generated 
for this study. Residues targeted are indicated with an asterisk. (B) HEK-293T cells were 
transfected with the indicated plasmids together with siMps1 before enrichment in 
mitosis and immunoblotting with the indicated antibodies. (C) Cells expressing indicated 
Mps1 constructs and siMps1 were synchronized in mitosis before fixation and 
immunostaining as shown. Quantification of pT686/CREST ratios is shown. **** 
p<0.0001 (D) HeLa cells expressing the indicated constructs, together with siMps1 were 
fixed and immunostained as indicated. Scale bar = 5µm. (E) Quantification of the MYC-
Mps1/CREST ratio from (D), * p<0.05, *** p<0.001.  (F) Pull-down of indicated MYC-
GFP-tagged Mps1 with GST-CHHEC1.  
Figure 4. Residues 40-49 form an NTE-specific kinase autoinhibitory module: (A) In 
vitro kinase assay of MYC-GFP-Mps1 constructs. Coomassie Blue staining indicated 
equal loading. Quantification of Mps1 autophosphorylation, data are means ± S.E.M,  n = 
3. * p<0.05 and ** p<0.01. (B) Immunoblotting with the indicated antibodies of the 
various MYC-Mps1 mutant proteins. (C) MYC immunoprecipitates from cells expressing 
the indicated MYC-Mps1 constructs were resolved by SDS-PAGE and immunoblotted as 
shown. (D) Cells were treated as in (C) enriched in mitosis with nocodazole and 
immunoblotted as indicated. See also Figures S4, S5. 
 
Figure 5. The Mps1 NTE interacts directly with the kinase domain: (A) A 
bacterially-expressed, 6xHIS-tagged N-terminal fragment of Mps1 (residues 1-301) was 
subjected to limited proteolysis, resolved by SDS-PAGE and identified by mass 
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spectrometry, n=2. (B) Mps1 N- and C-terminal fragments were mixed, 
immunoprecipitated with an antibody specific for Mps1’s C-terminus, resolved by SDS-
PAGE, and detected using an anti-His HRP-conjugated antibody, n>3. (C) Mps1-C (510-
809) alone or mixed with Mps1-N (1-225) was subjected to velocity sedimentation on a 
5-20% glycerol gradient. Fractions were resolved by SDS-PAGE and detected as in (B). 
Sedimentation peaks of conalbumin and ovalbumin are shown, n=2. (D) Elution profile 
of Mps1-C and Mps1-C + Mps1-N on a Superdex 200 size-exclusion column. Elution 
peaks of ovalbumin and chymotrypsin are indicated, n=2.  (E) Mps1-WT and Mps1-KD 
Coss-linkage map. Green: Mps1-WT linkages. Red: Mps1-KD linkages. Black: linkages 
in both Mps1-WT and Mps1-KD. (F) Mps1-WT-specific linkages; NTE - kinase links are 
marked in green. See also Tables S1 and S2. 
 
Figure 6. Relief of NTE-mediated autoinhibition is required for activity: (A and B) 
Stable Hela T-rex lines expressing MYC-GFP-Mps1-WT and mutants were treated with 
siMps1, synchronized in mitosis, fixed and immunostained as indicated. Scale bar = 5µm. 
Quantification of pMELT (A) and Mad2 (B) intensities. * p < 0.05, ** p <0.01, *** p < 
0.001, **** p < 0.0001. (C, D) Cells were treated as in (A) but fixed after overnight 
nocodazole treatment, and stained with the indicated antibodies. The mitotic index is 
shown, n=3. Cells counted ≥100 per cell lines per experiment. (E) Time-lapse 
microscopy of cells expressing indicated constructs. Mitotic timing is quantified. ≥50 
expressing cells were counted for each condition. n=2. *** p< 0.001, **** p< 0.0001. 
See also Figure S6 and Movies S1-S4. 
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Figure 7. Differential dephosphorylation kinetics of Mps1 substrates after chemical 
inhibition: (A) Stable HeLa T-rex lines expressing MYC-GFP-Mps1-WT or mutants 
were treated with siMps1 and synchronized in mitosis before fixation and 
immunostaining as shown. Lagging chromosomes in anaphase cells were determined by 
CREST staining. n=3, and ≥30 anaphases were counted for each condition. (B) Cells 
were treated as in (A) with the addition of nocodazole (7.5ng/ml). (C) Cells were treated 
with the indicated doses of reversine for 5 minutes before fixation and 
immunofluorescence as indicated. (D) Model of NTE phosphorylation and Mps1 
activation. See also Figure S7.  
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STAR Methods 
Key Resources table 
Contact for Reagent and Resource Sharing 
Further information and requests for resources and reagents should be directed to and will 
be fulfilled by the Lead Contact, Sabine Elowe 
(Sabine.Elowe@crchudequebec.ulaval.ca). 
Experimental Model and Subject Details 
Cell lines 
Human HeLa-S3 (Female), HeLa T-Rex (Female) and HEK293T cells were 
grown at 37°C with 5% CO2 in DMEM (Hyclone) supplemented with 10% fetal bovine 
serum or bovine growth serum (PAA) and pen/strep (100 µg/ml, Hyclone). U2OS cells 
expressing a 256-copy array of the Lac operator sequences were a kind gift of David 
Spector (CSHL) and were maintained in the presence of 100 mg/ml of hygromycin B. 
Hela Flp-in T-Rex cell line was used for generation of stable isogenic cell lines, and was 
a generous gift from Arshad Desai (Ludwig cancer research).  
Stable cell lines were generated using Flp-In system (Life Technologies). 
Transfection was done with TransIT®-LT1 (Mirus Bio) reagent according to the 
manufacturer’s instructions. The transfection reagent was mixed with the pOG44 Flp-
Recombinase Expression Vector and the pCDNA5/TO/FRT-Mps1 vector with a 1:1 ratio 
in OptiMEM media. Selection started 48h after the transfection in a DMEM media 
supplemented with 10% of bovine growth serum (PAA), pen/strep (100 µg/ml, Hyclone) 
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and in the presence of hygromycin B (200 mg/ml, MultiCell) and blasticidin (10 µg/ml, 
Gibco by Life Technologies). Media was replaced 3 times a week for 3 weeks and then 
single colonies were picked and grown separately. Expression of the Mps1 construct was 
then tested by IF and WB after 24h of tetracycline treatment.  
Drug treatments and transfections  
Drug treatments were realized as follows: nocodazole (Sigma, as indicated, 16h), 
thymidine (Acros Organics, 2 mM for 16 h), reversine (Sigma, 0.5 µM, 30min), taxol 
(Calbiochem, 0.2 µM, 16h). For experiments with stable cell lines, 24h before harvesting 
cells, 1µg/ml of tetracycline was added to express the protein of interest. Plasmid 
transfections were performed with PEI (polyethylenimine) at a 15:2 (PEI/DNA) ratio for 
HEK 293T cells and with TransIT® (Mirus Bio) for Hela S3 cells according to the 
manufacturer’s instructions. Endogenous protein depletion was carried out with DsiRNAs 
(IDT), using Oligofectamine™(Invitrogen) for HEK-293T cells and Hela-S3 or 
JetPRIME® (Polyplus-transfection) for stable cell line Hela Flp-In Trex and analyzed at 
48-72h after transfection. The Mps1 and Hec1 DsiRNA targets the following sequence: 
Mps1 A: 5’-GUAGAUUUCCACAGGGAUUCAAGAGUA- 3’ 
Mps1 B: 5’-AUACAGUGCCAUAAGUGGUUGCUAUUU-3’ 
Site-directed mutagenesis was performed using PCR and overlapping mutagenic primers. 
All constructs were verified by sequencing. 
Method Details 
Protein lysis and immunoprecipitation 
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Lysis of cell pellets for immunoblotting and immunoprecipitation was done with 
RIPA lysis buffer (150 mM Tris-HCl pH 7.5, 150 mM NaCl, 10 mM NaF, 1% NP-40, 
0.1% Na-deoxycholate and a protease and phosphatase inhibitor cocktail that included 20 
mM β-glycerophosphate, 0.1 mM sodium vanadate, 10 mM sodium pyrophosphate, 1 
mg/ml, leupeptin, 1 mg/ml, aprotinin and 1 mM AEBSF) or NP-40 lysis buffer (75 mM 
HEPES pH 7.5, 150mM KCl, 1.5 mM EGTA, 1.5 mM MgCl2, 10 % Glycerol, 0.075% 
NP-40 and the same protease and phosphatase inhibitor cocktail used in the RIPA buffer). 
For at least 30min, cells were lysed on an orbital shaker at 4°C and lysates were 
centrifuged at 20000xg for 10min at 4°C. The supernatant was collected and quantified 
using the BCA assay (Thermo Scientific) for all experiments.  Equalized protein lysates 
were used for all experiments. Immunoprecipitations were performed with anti-MYC 
antibodies bound to agarose beads overnight. Beads were washed 3 times with lysis 
buffer and 1 time with the corresponding buffer supplemented with extra 150 mM NaCl 
or KCl.  
In vitro kinase assays 
HEK 293T cells were transfected as described above and treated with nocodazole 
to synchronize cells in mitosis. The immunoprecipitates were given 1 final wash with 
Kinase Reaction Buffer (KRB: 50 mM Tris pH 7.4, 10 mM MgCl2, 1 mM DTT, 100 µM 
Sodium-orthovanadate, 10 mM Sodium Fluoride), and then incubated with KRB 
supplemented with 200 µM unlabeled ATP, 5 µCi ATP (32P) and MBP (1-2 Pg) substrate 
at 30°C for 30 min with agitation. The addition of SDS–PAGE sample buffer stopped the 
reaction. Samples were heated for 5 min at 95°C, and resolved by SDS PAGE for protein 
separation. The acrylamide gel was then stained with Coomassie Brilliant Blue, destained 
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to remove background, then dried on Whatman paper prior to visualization by 
autoradiography. 
Protein production and biochemistry 
pGEX-6P3-Hec1 CH domain plasmid was transformed into BL21 competent cells and 
selected on an ampicillin-treated LB plate. One colony was picked and was seeded in a 
10ml tube of LB-ampicillin, overnight at 37°C and 250 rpm. From this pre-culture, a 
200ml culture was started at 37°C and 250 rpm until an O.D value of 0.7-0.9. Synthesis 
of the recombinant protein was started by adding 0.5 mM of IPTG (MP biomedical) for 
5h at 30°C and 250 rpm. Bacteria were then centrifuged at 7700xg for 10min at 4°C and 
washed one time with PBS 1X and frozen. The next day, the pellet was then lysed in 
Lysis buffer II ([35] 25 mM Tris, 100 mM NaCl, 5% glycerol,1mM β-Mercaptoethanol, 
0.1% Triton-X-100, 20 mM E-glycerophosphate, 10 mM Na-pyrophosphate, 100 mM 
Na-Vanadate, 1µg/ml leupeptin, 1µg/ml aprotinin, 1mM AEBSF, pH8). After sonication 
(3 rounds of 30 seconds each at 10% amplitude, waiting for 0.5s between pulses and 
1min on ice between rounds) and 30min incubation on ice, the lysate was centrifuged for 
10min at 4°C and 13000 rpm. The supernatant was incubated on an orbital shaker for 2h 
at 4°C with glutathione/sepharose beads and then washed 2 times with lysis buffer, 1 time 
with TBS 1X and 1 time with GTB buffer (80 mM PIPES pH7, 2 mM MgCl2, 0.5 mM 
EGTA). Glycerol was added to 50% (v:v) and the beads were frozen. Mps1 N and C 
terminal fragments were purified from BL21(DE3) cells as hexahistidine fusions by 
standard nickel affinity chromatography.  To obtain active Mps1, baculovirus-infected 
Sf9 cells were lysed by sonication in insect cell breakage buffer (100 mM Tris, pH 7.5, 
20% sucrose, 4 mM EDTA, and 0.01% NP-40). GST-Mps1 was retrieved on glutathione-
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agarose beads (GE Healthcare), washed extensively with wash buffer (100 mM Tris, pH 
7.5, 20% sucrose, 4 mM EDTA, 500 mM KCl), and eluted in K buffer (20 mM potassium 
phosphate, pH 7.5, 10% glycerol, 0.5 mM EDTA, 0.5% NP-40, 25 mM glutathione, and 
2 mM DTT). Eluted material was stored in single-use aliquots at -80°C. Analytical size 
exclusion chromatography was performed on a Superdex 200 column with 50 mM Tris, 
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM DTT as the mobile phase. For velocity 
sedimentation, samples were loaded onto a 5-20% glycerol gradient (in 25 mM Tris, pH 
7.5, 0.01% NP-40, and 400 mM NaCl) and centrifuged at 250,000xg for 24 hours at 
4°C. Limited proteolysis was performed at 30ºC while samples were mixed at 300 rpm 
with 15 µg of Mps1(1-301) and diluted trypsin for 160 minutes. Reactions were 
terminated with SDS-PAGE sample buffer and analyzed by SDS-PAGE, Coomassie 
Brilliant Blue staining and mass spectrometry.  
Protein-binding assays 
For Hec1 CH domain pull-down assays, empty beads or beads bound to GST-
Hec1 CH domain were incubated for 1h with end-on mixing in GTB buffer containing 
5% glycerol and 1mg/ml of BSA. Beads were washed once and recombinant Mps1 
protein fragments were added to the beads in GTB buffer supplemented with 5% 
glycerol, 1mg/ml of BSA and 250 mM NaCl. The mix was incubated for a minimum of 
2h or overnight on an orbital shaker at 4°C. After binding, beads were washed 4 times 
with the supplemented GTB buffer. SDS-PAGE sample buffer was added and samples 
were heated to 95°C for 5min amd proteins were visualized by Western blotting. 
Cross-linking 
To find the optimal ratio of protein: cross-linker, 1 μg of Mps1 WT and 1 μg of Mps1 KD 
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at 0.1 μg/μl in 50 mM HEPES pH7.5, 250 mM KCl, 0.05% NP-40, 1 mM DTT were 
incubated with a 0-, 1-, 10-, 25-, 60-fold weight excess of BS3 for 2h on ice. The reaction 
was quenched by addition of ammonium bicarbonate to 50 mM. The cross-linked 
proteins were analyzed by SDS-PAGE and NATIVE-PAGE.  
For cross-linked peptides identification, 100 μg of Mps1 WT and 100 μg of Mps1 KD 
were cross-linked at 10:1 protein:BS3 ratio for 2h on ice and the reaction was quenched 
by addition of ammonium bicarbonate to 50 mM. Proteins were separated in NATIVE-
PAGE and stained with Coomassie blue.  
Sample preparation for mass spectrometry  
Bands containing the cross-linked Mps1 dimers were excised from gel and in-gel 
digested following standard protocols. The cross-linked peptides were extracted from gel 
slices, acidified to pH 3.0 with 0.5% acetic acid and fractionated using the SCX-
StageTip. High salt fractions were diluted four-fold with 0.1% TFA and desalted using 
C18-StageTips before MS analysis [57]. 
Mass spectrometry 
Cross-linked peptides were analyzed on LTQ-Orbitrap Velos (Thermo Scientific) on a 
180 min gradient, using CID collision energy at 35% and fragmenting the eight most 
intense peptide precursor ions with charge stages z = 3 or higher, per cycle. MS spectra 
were recorded at 100000 resolution, and MS/MS spectra at 7500 resolution, both in the 
Orbitrap.  
Database searching 
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The MS/MS spectra peak lists were generated from the raw data files using the Quant 
module of MaxQuant v. 1.0.11.2 at default parameters, except for choosing 200 as ‘top 
MS/MS peaks per 100 Da’. Cross-linked peptide spectra were searched using the 
software package Xi (ERI, Edinburgh) against Mps1 sequence uploaded from SwissProt. 
Search parameters: MS tolerance 6 ppm, MS/MS tolerance 20 ppm, fixed modification 
carbamidomethyl on cysteine, variable modifications: oxidation (Met), DST/BS3-OH 
(Lys), DST/BS3-NH2 (Lys), the ‘Max. missed cleavages' was set to 4. Matched spectra 
and cross-linked peptide candidates were returned by Xi in pairs. The highest scored 
matched spectra were validated manually, and to each spectral match a confidence was 
allocated. A high-confidence match indicates that for the longer peptide almost all, and 
for shorter peptides a minimum of three fragments were matched and all major peaks in 
the spectrum were accounted for. A low-confidence match indicates that one peptide 
matched essentially all observed fragments and a second peptide had up to three 
fragments matched with most of the peaks in spectrum explained. Reverse peptide 
sequences were used as a decoy search. All matches had to be highest ranking and 
unambiguous in the target and decoy search. 
Immunofluorescence  
Cells were grown on coverslips and arrested in mitosis either by nocodazole (330 
nM) or by 10–12h release from thymidine block. For experiments with Hela Flip-in T-rex 
cells expressing Mps1 stably, cells were grown on coverslips coated with a solution of 
PEI 25 µg/ml and 150 mM NaCl. Cells were fixed in PTEMF buffer (0.2% Triton X-100, 
20 mM PIPES pH 6.8, 1 mM MgCl2, 10 mM EGTA and 4% formaldehyde) for 10min or 
an Mps1-specific fixation (5min incubation with 1% formaldehyde in PBS, followed by 
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0.1 M glycine treatment as a quencher for 1h and 0.1% Triton X-100 for 3min to 
permeabilize cells) when visualizing Mps1. Before starting immunofluorescence, 
coverslips were incubated for at least 30 min with 3% BSA in PBS-T 0.2%. Coverslips 
were incubated with primary and secondary antibodies for 2h and 1h respectively at room 
temperature, except for Mps1 pT686, pSKA3, and Knl1 pT875 (pMELT), which were 
incubated at 4°C overnight in humidified chambers. 
Antibodies were used at 1 µg/ml, unless otherwise indicated, as follows: anti-MYC 
(9E10, Thermo Scientific), anti Knl1 pT875 (1:2000, gift from Dr Yoshinori Watanabe, 
University of Tokyo), anti-Mps1 (1mg/ml for WB and 5 mg/ml for IF, Sigma), Rabbit 
polyclonal phosphospecific antibodies against Mps1 T686, T676 and S821[11], Rabbit 
polyclonal phosphospecific antibody against Mps1 T33 (1:500) was generated against 
phosphopeptide CKNEDL(pT)DELS, anti Mad2 (4µg/ml, [50])  anti-GFP (1:500, 
Roche), anti-α-tubulin (DM1A, Santa Cruz Biotechnology), CENP-C (1:1000, MBL 
International), CREST anti-centromere serum (1:1000, ImmunoVision), and Hoechst 
33342 (1µg/ml, Sigma). An antibody specific for Mps1’s C-terminus (Santa Cruz 
Biotechnology; sc-540) was used for Mps1 immunoprecipitations. Hexahistidine-
fragments were detected using horseradish peroxidase-conjugated anti-histidine tag 
monoclonal antibody (Thermo Fisher). Dylight series secondary antibodies (Thermo 
Fisher) or (Jackson ImmunoResearch) were used for immunofluorescence (1:1000) and 
horseradish peroxidase-coupled secondary antibodies (Jackson ImmunoResearch) were 
used for western blotting (1:10000). 
Microscopy and live cell imaging 
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All images were acquired by confocal microscopy on an inverted Olympus IX80 
microscope equipped with a WaveFX-Borealin-SC Yokogawa spinning disc (Quorum 
Technologies) and an Orca Flash4.0 camera (Hamamatsu). Metamorph software 
(Molecular Devices) was used to perform image acquisition. Optical sections were 
acquired with identical exposure times for each channel within an experiment and then 
projected into a single picture using ImageJ (rsb.info.nih.gov). For image processing 
Image J or Photoshop were used and all images shown in the same figure have been 
identically scaled.  Live cell imaging was performed on the above indicated microscopy 
system that is also equipped with a motorized stage (ASI) and an incubator with 
atmospheric CO2 heated to 37°C. Mps1 stable cell lines were subjected to depletion of 
endogenous Mps1 for 72 hours, then synchronized in mitosis after a further 16h block 
with thymidine.  Image acquisition was started 7h after release at 4min intervals. Only 
cells visibly expressing the GFP-tagged Mps1 were included in subsequent analysis. 
 
Quantification and Statistical Analysis 
Unless otherwise stated, all experiments were performed in triplicate. Image 
quantification was realized using Image J. For measurement of signal intensities at 
kinetochores, the CREST, CENP-C or MYC signal were used to generate a binary mask 
to include kinetochore and centromere signals. Integrated signal intensity was measured 
in all relevant channels and intensities indicated are values relative to CREST, CENP-C 
or MYC, unless otherwise stated. A minimum of ten cells was quantified per condition 
for all experiments involving kinetochore quantification. All statistical analysis was 
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performed with Sigmaplot. Data are expressed as means ± S.E.M. The data were 
analyzed by ANOVA (one or two way) with Bonferroni’s multiple comparison tests for 
determination of the significance of the differences or as otherwise indicated. Statistical 
significance was considered with a P-value of <0.05. The symbols * were used in the 
different graphics to represent the P-value: *P<0.05, ** P<0.01, *** P<0.001, **** 
P<0.0001.  
Data and Software Availability 
All MS cross-links of Mps1-WT and Mps1-KD as supplied in Tables S1 and S2. 
 
Movie S1. Example of a MYC-GFP-Mps1-WT expressing cell in mitosis, Related to 
Figure 6.  
Movie S2. Example of a MYC-GFP-Mps1-KD expressing cell in mitosis, Related to 
Figure 6   
Movie S3. Example of a MYC-GFP-Mps1-'NTE expressing cell in mitosis, Related 
to Figure 6   
Movie S4. Example of a MYC-GFP-Mps1-'40-49 expressing cell in mitosis, Related 
to Figure 6   
Table S1. MS/MS identification of crosslinked peptides from Mps1-WT, Related to 
Figure 5.  
39 
 
Table S2. MS/MS identification of crosslinked peptides from Mps1-KD, Related to 
Figure 5.  
 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
anti-MYC (Clone 9E10) Thermo Fisher 
Scientific 
Cat# MA1-980-1MG, 
RRID:AB_2537627 
anti Knl1 pT875 Gift of Dr. Yoshiri 
Watanabe, University 
of Tokyo 
N/A 
Anti-Mps1 Sigma-Aldrich Cat# M5818, 
RRID:AB_261965 
Anti-Mps1 pT33 This study N/A 
Anti-Mps1 pT676 Eyers Lab [11] N/A 
Anti-Mps1 pT686 Eyers Lab [11] N/A 
Anti-Mps1 pS821 Eyers Lab [11] N/A 
Anti-Mps1 C-terminus Santa Cruz 
Biotechnology  
Cat# sc-540, 
RRID:AB_632567 
Anti-Mad2 Clone #107-276-3 Gift of Erich Nigg [50] N/A  
Anti-α-tubulin (Clone DM1A) Santa-Cruz 
Biotechnology 
Cat# sc-32293, 
RRID:AB_628412 
Anti-Cenp-C MBL International Cat# PD030, 
RRID:AB_10693556 
Anti- polyHistidine-HRP peroxidase Sigma Cat# A7058 
Anti-GFP Sigma-Aldrich (Roche) Cat# 11814460001, 
RRID:AB_390913 
Ant-CREST Immunovision Cat# HTC-0100 
Bacterial and Virus Strains  
Escherichia Coli: BL21(DE3) EMB Millipore Cat. No. #69450 
 
Spodoptera frugiperda: SF9  ATCC CRL-1711, CLS Cat# 
604328/p700_Sf9, 
RRID:CVCL_0549 
Biological Samples   
   
   
   
   
   
Chemicals, Peptides, and Recombinant Proteins 
Nocodazole Sigma-Aldrich Cat# M1404-10MG 
Taxol (Paclitaxel, Taxus sp) Calbiochem Cat# 580555 
Reversine Sigma-Aldrich Cat# R3904-1MG 
BI2536 Reagents Direct 88-Q71 
Thymidine Acros Cat# 226740050 
Hygromycin B Wisent (MultiCell) Cat# 450-141-XL 
Tetracycline Sigma-Aldrich Cat# T7660-5G 
Polyethylenimine Polysciences inc. Cat# 23966 
bis(sulfosuccinimidyl)suberate (BS3) Thermo Fisher 
Scientific 
Cat# 21580 
Blaticidin S HCL Gibco Cat# A11139-03 
Key Resource Table
Mps1 T33 phosphopeptide: CKNEDL(pT)DELS Custom synthesis,  
EZBiolab 
N/A 
Critical Commercial Assays 
Pierce BCA Protein Assay Kit ThermoScientific Cat# 23225 
Trans-IT transfection kit Mirus Bio Cat# MIR2305 
JetPRIME Polyplus-transfection Cat#  114-07 
Oligofectamine Invitrogen Cat# 12252-011 
glutathione-agarose beads (Glutathione Sepharose™ 
4B Media) 
GE Healthcare Cat# 45-000-139 
Deposited Data 
   
   
   
   
   
Experimental Models: Cell Lines 
Human: HeLa S3 E.Nigg Lab ATCC Cat# CRL-
7924, 
RRID:CVCL_0058 
Human: HeLa T-REX A.Desai Lab N/A 
Human: HEK 293T E.Nigg Lab ATCC Cat# CRL-
3216, 
RRID:CVCL_0063 
Human: hTERT-RPE1 E.Nigg Lab ATCC Cat# CRL-
4000 
Experimental Models: Organisms/Strains 
   
   
   
   
   
   
Oligonucleotides 
Mps1 DsiRNA Oligos A: 5’-
GUAGAUUUCCACAGGGAUUCAAGAGUA- 3’ 
 
DTI N/A 
Mps1 DsiRNA Oligos B: 5’-
AUACAGUGCCAUAAGUGGUUGCUAUUU-3’ 
 
DTI N/A 
GL2i (Luciferase Gl2 siRNA)  sense : 5’-UCG AAG UAU 
UCC GCG UAC G(dT)(dT)- 3’, anti-sense : 5’-CGU ACG 
CGG AAU ACU UCG A(dT)(dT)-3’ 
Life Technologies  N/A 
Recombinant DNA 
pcDNA 3.1-3xmyc-(A)-Mps1 WT Ref 29, 30 N/A 
pcDNA 3.1-3xmyc-(A)-Mps1 KD Red 29,30 N/A 
pcDNA 3.1-3xmyc-(A)-Mps1 ΔNTE This study N/A 
pcDNA 3.1-3xmyc-(A)-Mps1 Δ7 This study N/A 
pcDNA 3.1-3xmyc-(A)-Mps1 5A This study N/A 
pcDNA 3.1-3xmyc-(C)-Mis12-Mps1 ΔNTE This study N/A 
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 WT This study N/A 
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 KD This study N/A 
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 Δ40-49 This study N/A 
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 Δ19/29 This study N/A 
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 ΔNTE This study N/A 
pcDNA 5 TO/FRT-3xmyc-(C)-Mps1 40-49/5A This study N/A 
PGEX 6P3 GST-HEC1 CH domain This study N/A 
pcDNA 3.1-3xmyc-A-Mps1 ΔTPR This study N/A 
pcDNA 3.1-3xmyc-(A)-FKBP-Mps1 WT This study N/A 
pcDNA 3.1-3xmyc-(A)-FKBP-Mps1 KD This study N/A 
pcDNA 3.1-3xmyc-(C)-FKBP-Mps1 ΔNTE This study N/A 
pcDNA 3.1-3xmyc-(A)-LacI -Mps1WT This study N/A 
pcDNA 3.1-3xmyc-(A)-LacI -Mps1 KD This study N/A 
pcDNA 3.1-3xmyc-(C)-LacI -Mps1 Δ49 This study N/A 
pcDNA 3.1-3xmyc-(A)-Mps1 Δ19-29 This study  N/A 
pcDNA 3.1-3xmyc-(A)-Mps1 Δ40-49 This study N/A 
pDest17-Mps1 (1-301) This study N/A 
pDest17-Mps1 (1-225) This study N/A 
pDest17-Mps1 (27-225) This study N/A 
pDest17-Mps1 (302-856) This study N/A 
pDest17-Mps1 (510-801) This study N/A 
pDest20-Mps1-WT This study N/A 
pDest20-Mps1-KD This study N/A 
Software and Algorithms 
   
   
   
   
   
Other 
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 Figure S1: Verification of Mps1 siRNA efficiency, related to Figure 1. 
siRNA GL2 (75nM) or siRNA Mps1-A (25nM)+Mps1-B (50nM) were transfected in 
either HeLa S3 (A) or HeLa T-Rex (B) cell lines for 72h before cells were lysed and 
cleared lysates were blotted for Mps1 (upper panels) and tubulin (lower panels).  (C) 
pMELT signals in HeLa T-Rex cells depleted of endogenous Mps1. Cells were 
synchronized in mitosis after release from thymidine arrest before being fixed and 
immunostained for pMELT (Red) for, MYC1 (Green), CREST (Cyan) and Hoechst 
(Blue). Scale bar = 5µm. The graph shows the quantification of the relative pMELT 
intensity from. **** P < 0.0001.  
Supplemental Data
  
Figure S2: The NTE contributes to Mps1 mitotic hyperphosphorylation, related to 
Figure 1 
(A) HEK 293T cells were transiently transfected with MYC-Mps1 constructs together 
with siMps1, and enriched in mitosis by nocodazole treatment. Cells were treated as 
indicated with 0.5 µM reversine 30min before harvesting. MYC (top panel) and α-tubulin 
(bottom panel) immunoblotting were performed on equalized lysates. 
 
Figure S3: Increased local concentration and transactivation contribute to Mps1 
activation, related to Figure 2. 
(A) HeLaS3 cells were simultaneously transfected with the indicated constructs and 
siMps1 and fixed 10h after release from a thymidine arrest. Cells were immunostained 
against MYC (Red), CREST (Green), and DNA was visualized by Hoechst (Blue). Scale 
bar = 5µm. (B) RPE-1 cells treated for 16h with 3.3µM nocodazole, 0.2µM taxol or 
DMSO, and then fixed. The graph shows the quantification of the pMELT signal relative 
to total Mps1. **** p< 0.0001. (C) Representative images of cells quantified in (B). Cells 
were immunostained against MYC (Green), pMELT (Red), CENP-C (Cyan) and Hoechst 
(Blue). Scale bar = 5µm. (D) HeLa cells treated for 16h with 3.3µM nocodazole, 0.2µM 
taxol or DMSO, and then fixed. Cells were immunostained against MYC (Green), 
pMELT (Red), CENP-C (Cyan) and DNA was marked by Hoechst (Blue). Scale bar = 
5µm. See Figure 2F for quantification. (E) quantitation of the Mps1 signal versus Cenp-C 
at kinetochores for the data in Figure 2F. 
 
 
Figure S4. Characterization of the anti-pT33 phosphospecific Mps1 antibody, 
related to Figure 4.  
(A) MYC-Mps1 was immunoprecipitated from nocodazole arrested HEK 293T cells and 
left untreated or was treated with calf-intestinal phosphatase for 60min at 37°C before the 
reaction was stopped with SDS-PAGE sample buffer. Resolved samples were probed 
with pT33 antibodies before stripping and reprobing with MYC. (B) Cells expressing 
MYC-Mps1 -WT and -KD were arrested in mitosis with nocodazole and the MYC-Mps1 
proteins were immunoprecipitated from equalized lysates before being resolved by SDS-
PAGE and immunoblotted with the indicated antibodies.  
 
 
 
 Figure S5. Relief of Mps1 NTE-mediated autoinhibition does not require significant 
Plk1 activity, related to Figure 4. 
 (A) HEK 293T cells were transfected with the indicated Mps1-WT and -KD constructs. 
Lysates were blotted for T33 and T686 phosphorylation. Reblotting with MYC 
demonstrates equal loading. (B) Expression of Mps1 and Plk1 used in (C) and (D). In 
vitro kinase assay of Mps1 1-210 and Mps1 1-210 Δ40-49 recombinant fragments using 
full length Plk1 (C) and full length Mps1 (D). (E) Quantitation of recombinant Mps1 
fragment phosphorylation from (D). (F) MYC-GFP-Mps1 WT and Δ40-49 expressing 
HeLa cells were treated with nocodazole overnight before addition of MG132 and the 
additional inhibitors as indicated.  Fixed cells were stained with MYC, Mps1 pT686, and 
CREST antisera. Relative quantification of pT686 signals is shown. **p < 0.01. 
 
Figure S6. Characterization of the HeLa T-Rex stable cell lines used in this study, 
related to Figure 6.  
(A) Immunofluorescence of HeLa T-Rex cell lines expressing 3xMYC-GFP-MPS1 
constructs. Cells were stained for MYC (green), CREST (cyan) and DNA was visualized 
with Hoechst (blue). Scale bar=5μM. (B) Graphic representing the percentage of GFP-
positive cells of the indicated cell lines. A minimum of 100 cells was counted per cell 
lines. (C) HeLa-T-Rex cell lines stably expressing the indicated constructs were enriched 
in mitosis by nocodazole treatment before fixation and staining with the indicated 
antibodies.  (D) Quantitation of the relative kinetochore intensity of the Mps1 from the 
HeLa-T-Rex cell lines in (C).  (E) Time (mins) in mitosis (nuclear envelope breakdown 
to anaphase onset) of siGL2 and siMPS1 treated cells, the control of the experiment in 
(Figure 6E). A minimum of 50 expressing cells was counted for each condition. n=2. 
Scale bar = 10µm. **** p < 0.0001. (F) Stills from representative cells of each cell line 
from live-cell experiments in (Figure 6E and Figure S6E). 
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Figure S7. Mps1 NTE and TPR crosslinks mapped onto the Mps1 kinase domain, 
related to Figure 7.  
Unique crosslinks identified between the NTE and the kinase domain of Mps1 (brown) 
and the TPR and the kinase domain of Mps1 (red) are mapped on to the structure of the 
inhibited Mps1 kinase domain (PDB ID: 2ZMC).  The catalytic loop is shown in blue 
whereas the activation loop is in green.  (A) and (B) are rotated by 45º. Mapping the 
kinase domain residues identified in the cross-links with the NTE (and TPR) onto the 
Mps1 kinase structure suggests that the NTE region interacts with the N-terminal lobe 
region that is defined by the residues V539FQVLNEKK547 and Q579QHSDKIIR587 
(numbering according to Mps1 isoform 1, NCBI NP_003309.2). The crystal structure of 
Mps1 kinase domain in its inhibited conformation shows that residues of the 
Q579QHSDKIIR587 region form part of α-helix C and are in close spatial proximity (eg, 5 
Å or less) to the activation and the catalytic loops. The C-terminal lobe region that is 
defined by the residues K625SYWK629 and the more C-terminal region C770CLKR774 both 
interact with the TPR motif. The activation loop (residues 672-680) and the loop between 
helices αF and αEF (residues 700-708) are flexible and disordered. The residues 
K625SYWK629 form part of αE helix and are in close proximity to the catalytic loop 
(particularly the side chain of Tyrosine residue Y627). Because the C770CLKR774 residues 
form part of αH helix, the intramolecular interaction of the TPR motif with the kinase 
domain may affect the local conformation of the activation loop, thus contributing to 
modulate Mps1 catalytic activity. Two positively charged residues, K708 and K710, 
which are mapped onto the loop connecting αF and αEF and in close proximity to the 
P+1 and the activation loops, stabilize the active conformation. 
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